{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:31:56Z","timestamp":1793680316824,"version":"4.5.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DA055933"],"award-info":[{"award-number":["K23DA055933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA044878"],"award-info":[{"award-number":["R01DA044878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.josat.2023.209261","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T06:03:52Z","timestamp":1702533832000},"page":"209261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study"],"prefix":"10.1016","volume":"158","author":[{"given":"Benjamin T.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Nienaltow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Torres-Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13722-021-00244-8","article-title":"Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: A systematic review","volume":"16","author":"Adams","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.josat.2023.209261_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/ajad.13135","article-title":"Microinduction of bupre- norphine\/naloxone: A review of the literature","volume":"30","author":"Ahmed","year":"2021","journal-title":"American Journal on Addictions"},{"issue":"5","key":"10.1016\/j.josat.2023.209261_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using bupre- norphine: Five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ajad.13069","article-title":"Method for successfully inducting individuals who use illicit fentanyl onto buprenor- phine\/naloxone","volume":"30","author":"Antoine","year":"2021","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.josat.2023.209261_bb0025","author":"Askari"},{"issue":"11","key":"10.1016\/j.josat.2023.209261_bb0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMp1108649","article-title":"Moving beyond parity--mental health and addiction care under the aca","volume":"365","author":"Barry","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209261_bb0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"4","key":"10.1016\/j.josat.2023.209261_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/ADM.0000000000000947","article-title":"Low dose buprenorphine induction with full agonist overlap in hospitalized patients with opioid use disorder: A retrospective cohort study","volume":"16","author":"Bhatraju","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(03)00071-1","article-title":"Cessation of methadone maintenance treatment using bupre- norphine: Transfer from methadone to buprenorphine and subsequent buprenorphine reductions","volume":"71","author":"Breen","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.josat.2023.209261_bb0050","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1093\/pm\/pnz361","article-title":"Medical record documentation about opioid tapering: Examining benefit-to-harm framework and patient engagement","volume":"21","author":"Buonora","year":"2020","journal-title":"Pain Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209261_bb0055","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1097\/ADM.0000000000000864","article-title":"Low-dose buprenorphine initiation in hospitalized adults with opioid use disorder: A retrospec- tive cohort analysis","volume":"16","author":"Button","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209261_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108234","article-title":"Inpatient link to peer recovery coaching: Results from a pilot randomized control trial","volume":"215","author":"Byrne","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2023.209261_bb0065","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1097\/ADM.0000000000000623","article-title":"Transition from methadone to buprenor- phine using a short-acting agonist bridge in the inpatient setting: A case study","volume":"14","author":"Callan","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209261_bb0070","author":"Center for Behavioral Health Statistics and Quality"},{"issue":"2S Suppl 1","key":"10.1016\/j.josat.2023.209261_bb0075","first-page":"1","article-title":"The asam national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","author":"Cunningham","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209261_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e31829727b2","article-title":"Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","volume":"7","author":"Cunningham","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209261_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0306-4603(93)90036-9","article-title":"Barriers to treatment: Why alcohol and drug abusers delay or never seek treatment","volume":"18","author":"Cunningham","year":"1993","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2023.209261_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addbeh.2017.05.010","article-title":"Predictors of buprenorphine treatment success of opioid dependence in two Baltimore city grassroots recovery programs","volume":"73","author":"Damian","year":"2017","journal-title":"Addictive Behaviors"},{"issue":"6","key":"10.1016\/j.josat.2023.209261_bb0095","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/10826089709039377","article-title":"Abstinence fear in methadone mainte- nance withdrawal: A possible obstacle for getting off methadone","volume":"32","author":"Eklund","year":"1997","journal-title":"Substance Use and Misuse"},{"issue":"12","key":"10.1016\/j.josat.2023.209261_bb0100","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","article-title":"Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: A propensity-matched analysis","volume":"34","author":"Englander","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1521-0391.2013.12074.x","article-title":"Predictive factors for relapse in patients on buprenorphine maintenance","volume":"23","author":"Ferri","year":"2014","journal-title":"American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.josat.2023.209261_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0477","article-title":"Office-based addiction treatment retention and mortality among people experiencing homelessness","volume":"4","author":"Fine","year":"2021","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.josat.2023.209261_bb0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5055\/jom.2022.0752","article-title":"Transferring patients from high-dose methadone to buprenorphine: A retrospective case series","volume":"18","author":"Foran","year":"2022","journal-title":"Journal of Opioid Management"},{"issue":"10","key":"10.1016\/j.josat.2023.209261_bb0120","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/pm\/pnw078","article-title":"Patients\u2019 perspectives on tapering of chronic opioid therapy: A qualitative study","volume":"17","author":"Frank","year":"2016","journal-title":"Pain Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/add.15998","article-title":"The association between buprenorphine treatment duration and mortality: A multi-site cohort study of people who discontinued treatment","volume":"118","author":"Glanz","year":"2023","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","article-title":"A narrative pharmacological review of buprenorphine: A unique opioid for the treatment of chronic pain","volume":"9","author":"Gudin","year":"2020","journal-title":"Pain and therapy"},{"key":"10.1016\/j.josat.2023.209261_bb0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/SAR.S109919","article-title":"Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: The bernese method","volume":"7","author":"H\u00e4mmig","year":"2016","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2023.209261_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York city","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209261_bb0145","article-title":"\u201cThe doctor says you cannot have [buprenorphine]\u201d autonomy and use of prescribed or non-prescribed buprenorphine","volume":"1-7","author":"Hayes","year":"2021","journal-title":"Substance Use and Misuse"},{"issue":"2","key":"10.1016\/j.josat.2023.209261_bb0150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/ADM.0000000000000854","article-title":"Clinical case conference: Strategies for transferring from methadone to buprenorphine","volume":"16","author":"Hill","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209261_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jsat.2017.05.010","article-title":"Very early disengagement and subsequent re-engagement in primary care office based opioid treatment (obot) with buprenorphine","volume":"79","author":"Hui","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209261_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108140","article-title":"Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program","volume":"119","author":"Jakubowski","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209261_bb0170","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.2147\/NDT.S331442","article-title":"Factors that affect patient attrition in buprenorphine treatment for opioid use disorder: A retrospective real-world study using electronic health records","volume":"17","author":"Ker","year":"2021","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13181-021-00858-z","article-title":"Methadone vs. buprenorphine for in-hospital initiation: Which is better for outpatient care retention in patients with opioid use disorder?","volume":"18","author":"Kessler","year":"2022","journal-title":"Journal of Medical Toxicology"},{"issue":"4","key":"10.1016\/j.josat.2023.209261_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ajad.12869","article-title":"Rapid micro-induction of buprenorphine\/naloxone for opioid use disorder in an inpatient setting: A case series","volume":"28","author":"Klaire","year":"2019","journal-title":"American Journal on Addictions"},{"issue":"5","key":"10.1016\/j.josat.2023.209261_bb0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ADM.0000000000000059","article-title":"Unobserved \u201chome\u201d induction onto buprenorphine","volume":"8","author":"Lee","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"8","key":"10.1016\/j.josat.2023.209261_bb0190","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209261_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ADM.0000000000000855","article-title":"Strategies for transfer from methadone to buprenorphine for treatment of opioid use disorders and associated outcomes: A systematic review","volume":"16","author":"Lintzeris","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209261_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108248","article-title":"Peer recovery coaches in general medical settings: Changes in utilization, treatment engagement, and opioid use","volume":"122","author":"Magidson","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2023.209261_bb0205","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1176\/appi.ps.201700363","article-title":"Three-year retention in buprenorphine treatment for opioid use disorder among privately insured adults","volume":"69","author":"Manhapra","year":"2018","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.josat.2023.209261_bb0210","author":"MDCalc \u00a9"},{"issue":"6","key":"10.1016\/j.josat.2023.209261_bb0215","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/emp2.12289","article-title":"Microdosing and standard-dosing take-home buprenorphine from the emergency department: A feasibility study","volume":"1","author":"Moe","year":"2020","journal-title":"Journal of the American College of Emergency Physicians Open"},{"key":"10.1016\/j.josat.2023.209261_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106740","article-title":"Short communication: Systematic review on effectiveness of micro-induction approaches to buprenorphine initiation","volume":"114","author":"Moe","year":"2021","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.josat.2023.209261_bb0225","author":"National Center for Health Statistics"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0230","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10550887.2012.759872","article-title":"A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction","volume":"32","author":"Neumann","year":"2013","journal-title":"Journal of Addictive Diseases"},{"issue":"4","key":"10.1016\/j.josat.2023.209261_bb0235","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jsat.2012.08.010","article-title":"Prescription opioid abuse, chronic pain, and primary care: A co-occurring disorders clinic in the chronic disease model","volume":"43","author":"Pade","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209261_bb0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2007.04.006","article-title":"Sublingual buprenorphine\/ naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone","volume":"90","author":"Rosado","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209261_bb0245","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/19.124","article-title":"Rapid induction therapy for opioid-use disorder using buprenorphine transdermal patch: A case series","volume":"24","author":"Saal","year":"2020","journal-title":"The Permanente Journal"},{"key":"10.1016\/j.josat.2023.209261_bb0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209261_bb0255","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201d: Buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2023.209261_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107958","article-title":"On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine","volume":"210","author":"Silverstein","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209261_bb0265","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5055\/jom.2013.0152","article-title":"Consumer attitudes about opioid addiction treatment: A focus group study in New York city","volume":"9","author":"Sohler","year":"2013","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.josat.2023.209261_bb0270","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"British Medical Association"},{"issue":"5","key":"10.1016\/j.josat.2023.209261_bb0275","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.josat.2023.209261_bb0280","first-page":"200","article-title":"Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?","volume":"63","author":"Srivastava","year":"2017","journal-title":"Canadian Family Physician"},{"issue":"5","key":"10.1016\/j.josat.2023.209261_bb0285","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/aid.2019.0153","article-title":"Predictors for poor linkage to care among hospitalized persons living with hiv and co-occurring substance use disorder","volume":"36","author":"Summers","year":"2020","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13722-023-00365-2","article-title":"Substance use disorder bridge clinics: Models, evidence, and future directions","volume":"18","author":"Taylor","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"issue":"10","key":"10.1016\/j.josat.2023.209261_bb0295","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/phar.2313","article-title":"Transitioning hospitalized patients with opioid use disorder from methadone to buprenorphine without a period of opioid abstinence using a microdosing protocol","volume":"39","author":"Terasaki","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.josat.2023.209261_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","article-title":"Addiction consultation services - linking hospitalized patients to outpatient addiction treatment","volume":"79","author":"Trowbridge","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209261_bb0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its conse- quences for healthcare delivery: Systematic review","volume":"131","author":"Van Boekel","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2023.209261_bb0310","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","volume":"16","author":"Varshneya","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209261_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108848","article-title":"Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic","volume":"141","author":"Wakeman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8","key":"10.1016\/j.josat.2023.209261_bb0320","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity","volume":"32","author":"Wakeman","year":"2017","journal-title":"Journal of General Internal Medicine"},{"issue":"2 Suppl","key":"10.1016\/j.josat.2023.209261_bb0325","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2023.209261_bb0330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/ADM.0000000000000745","article-title":"Hospital-based buprenorphine micro-dose initiation","volume":"15","author":"Weimer","year":"2021","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209261_bb0335","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"Journal of Neurosciences in Rural Practice"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0345","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2010.04.001","article-title":"Factors associated with complicated buprenorphine inductions","volume":"39","author":"Whitley","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2023.209261_bb0350","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13722-021-00220-2","article-title":"Comparing rapid micro-induction and standard induction of buprenorphine\/ naloxone for treatment of opioid use disorder: Protocol for an open-label, parallel-group, superiority, randomized controlled trial","volume":"16","author":"Wong","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2023.209261_bb0355","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2023.209261_bb0360","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s11481-018-9801-x","article-title":"Correlates of long-term opioid abstinence after randomization to methadone versus buprenorphine\/naloxone in a multi-site trial","volume":"13","author":"Zhu","year":"2018","journal-title":"Journal of Neuroimmune Pharmacology"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923003132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923003132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:11:44Z","timestamp":1778937104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923003132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":72,"alternative-id":["S2949875923003132"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209261","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209261"}}